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Abstract: Paracellular permeability is determined by the complex structures of junctions 
that  are  located  between  the  epithelial  cells.  Already  in  1996,  it  was  shown  that  the 
human probiotic  strain  Lactobacillus  plantarum  299v  and  the  rat-originating  strain 
Lactobacillus reuteri  R2LC  could  reduce  this  permeability  in  a  methotrexate-induced 
colitis model in the rat. Subsequently, many animal models and cell culture systems have 
shown  indications  that  lactobacilli  are  able  to  counteract  increased  paracellular 
permeability evoked by cytokines, chemicals, infections, or stress. There have been few 
human studies focusing on the effect of lactobacilli on intestinal paracellular permeability 
but recently it has been shown that they could influence the tight junctions. More precisely, 
short-term  administration  of  L.  plantarum  WCSF1  to  healthy  volunteers  increased  the 
relocation  of  occludin  and  ZO-1  into  the  tight  junction  area  between  duodenal 
epithelial cells. 
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1. Introduction 
A thin layer of epithelial cells, extending from the sphincter of the esophagus to the anus, transports 
nutrients  and  water  from  the  intestinal  content  while  also  functioning  as  a  barrier  to  antigenic 
molecules from food and commensal as well as pathogenic bacteria. The epithelium confers selective 
permeability through either transcellular or paracellular routes. Transfer of small molecules such as 
short-chain fatty acids, amino acids, electrolytes and sugars are transporter-mediated through cells 
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while  medium-sized  (up  to  approximately  600  Da  in  vivo  and  10  kDa  in  cell  lines)  hydrophilic 
compounds  are  transferred  paracellularly.  Protein-sized  molecules  are  normally  prohibited  from 
transport via the paracellular route (Figure 1) [1,2].  
The  paracellular  barrier  function  is  brought  about  by  complex  junctional  structures,  the  tight 
junctions (TJs) located apically between the enterocytes and the more basolateral adherens junctions, 
the desmosomes and the gap junctions. These complexes have long been known to transport fluids and 
molecules and to structurally anchor adjacent cells together. However, the junctional complexes are 
now known  to  also take  part in  transfer  of external  stimuli to the epithelial  cells  governing their 
proliferation and differentiation [3]. The current view is that the function of TJs is what is mainly 
responsible for the paracellular permeability [4]. 
Tight junctions are  made  up of transmembrane  proteins  such  as  occludins,  junctional  adhesion 
molecules (JAM) and claudins with an intra-cellular connection to the zonulins, which are members of 
the zonula occludens (ZO) family. These, in turn, are anchored to the cell’s actinomyosin cytoskeleton 
and the result is a structure that not only provides the epithelium with a barrier function but also, by 
rapid  assembly  and  disassembly,  changes  its  permeability  upon  different  stimuli  (Figure  1)  [5,6]. 
Moreover, they maintain the polarity of the epithelial cell, making it impossible for lipids and proteins, 
directed towards the luminal side, to move basolaterally [2]. The function of the TJs is dependent on 
levels and localization of junction proteins and also regulated by phosphorylation of the TJ proteins 
and  of  the  myosin  light  chain  (MLC).  The  latter  is  brought  about  by  different  kinases  and 
phosphorylases, and results in the fine-tuning of the paracellular permeability according to the cellular 
environment [5].  
Altered  intestinal  permeability,  as  a  result  of  increased  paracellular  permeability,  enhanced 
transcellular transport or even loss of epithelial cells, plays an important role in the pathogenesis in 
several critical conditions such as burns, major trauma and sepsis [6–8]. Impaired gut barrier function 
may take days to restore and could eventually lead to an increased translocation of intestinal bacteria 
into the body [9]. Under these circumstances the gut has been called ―the undrained abscess‖ [10], and 
has been regarded as a driving force towards multiple organ failure [11,12]. Bacterial translocation, 
which has been recorded in numerous animal models, is defined as passage of viable bacteria from the 
gastrointestinal tract to extra intestinal sites and could take place between, as well as through the 
epithelial cells. However, for obvious reasons, measurement of translocation in humans is difficult and 
so its significance in the clinical situation remains controversial [13]. 
Increased permeability of the intestinal epithelium, with alterations of the paracellular pathway and 
also in the transcytotic uptake of peptides, is also mentioned as part of the pathophysiology of many 
less  dramatic  diseases  [2,14].  Mediators  of  inflammation  such  as  reactive  oxygen  species  (ROS), 
endotoxin (lipopolysaccharide; LPS) and cytokines can induce disruption of TJs and thereby increase 
the  paracellular  permeability  [15].  Abnormal  intestinal  barrier  function  plays  a  pivotal  role  in 
inflammatory  bowel  disease  (IBD)  [16].  Type-1  diabetes  and  coeliac  disease  are  examples  of 
auto-immune  situations  where  increased  paracellular  permeability  has  been  implicated  in  the 
development of disease [17].  In  addition, a  barrier dysfunction  in the colonic mucosa of  Irritable 
Bowel Syndrome (IBS) patients that was the result of increased paracellular permeability, presumably 
by an altered expression of ZO-1, has been reported [18]. Moreover, stress is believed to contribute to 
induction of IBS as well as recurrence of intestinal inflammation and onset of food allergies, and Nutrients 2011, 3  
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stressful  stimuli  can  increase  paracellular  permeability  [19].  For  gastrointestinal  diseases,  altered 
intestinal permeability could certainly be a result of disease progression but there is evidence that it 
might be a primary event. Increased paracellular permeability is, for instance, predictive of relapse in 
inactive IBD patients and present in first-degree asymptotic relatives of patients with celiac disease [1]. 
Members of the Lactobacillus genus are a minor part of the normal intestinal microbiota in the 
colon but a much greater component higher up in the gut. The species that are most commonly found 
in  this  niche  are  Lactobacillus  paracasei,  Lactobacillus  salivarius,  Lactobacillus  rhamnosus, 
Lactobacillus fermentum and Lactobacillus plantarum [20]. Members of these species have also been 
encountered as having probiotic effects and have been challenged as such in many in vitro as well as  
in vivo studies. In this article, we are trying to picture the effects that this genus might have on the 
paracellular permeability in the gut. 
Figure 1. (A) Macroscopic arrangement and (B) microscopic composition of intercellular 
tight junctions; reproduced with permission from John Wiley and Sons [21]. 
 
2. Effects in Animal Models 
2.1. Methotrexate-Induced Colitis 
Methotrexate is a cytotoxic drug that interferes with folate metabolism and so decreases de novo 
synthesis of thymidine and purine, resulting in inhibition of rapidly dividing cells such as cancer cells. 
The fact that intestinal epithelial cells also divide rapidly renders them vulnerable to methotrexate.  
The  damage  is  characterized  by  decreased  intestinal  barrier  function,  infiltration  to  the  area  of Nutrients 2011, 3  
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neutrophils and macrophages and thereby an increasing amount of ROS at the site of injury. In the 
methotrexate-induced  colitis  model,  ROS  generated  by  chemotherapy  is  the  first  step  leading  to 
increased intestinal permeability and intestinal inflammation [22]. ROS has been reported to activate 
tyrosine kinase and phosphatidylinositol-3-kinase and alter the composition of the tight junctions that 
will affect the paracellular permeability [23,24]. 
Administration  of  L.  plantarum  DSM  9843  (299v)  and  Lactobacillus  reuteri  R2LC  in  a 
methotrexate-induced colitis model in the rat decreased intestinal permeability, as measured in the 
proximal as  well as  distal ileum and in  colon by Cr-EDTA clearance. This  molecule  is  found in 
increased quantities in urine while the gut permeability is enhanced and regarded as a probe that could 
be used for such measurements for both the small intestine and the colon. Translocation to mesenteric 
lymph nodes (MLNs), liver, spleen and arterial blood and endotoxin levels in plasma were decreased 
in these treatment groups and intestinal microflora was affected, showing less Enterobacteriaceae and 
Gram-negative anaerobes, especially in the rats treated with L. plantarum [25]. Pre-treatment for one 
week before administration of methotrexate, using cow’s milk fermented with Lactobacillus johnsonii 
and sheep’s milk fermented with Lactobacillus bulgaricus and Streptococcus thermophilus, was shown 
to  improve  small  intestinal  barrier  function  as  determined  by  the  lactulose/mannitol  ratio  [26]. 
Together with rhamnose, lactulose and mannitol are sugars that are often used as probes to monitor 
paracellular permeability, although they can only be used to illustrate the small intestine as they are 
broken down by the microbiota in the colon. 
2.2. Liver Injury Induced by D-Galactosamine 
The outcome of liver injury induced by D-galactosamine resembles clinical features of fulminant 
liver  failure  in  many  respects  [27].  D-galactosamine  is  a  hepatocyte-specific  inhibitor  of  RNA 
synthesis and has been shown to increase the sensitivity to LPS and to the pro-inflammatory cytokine 
tumor necrosis factor alpha (TNF-α) [28]. Increased gut permeability after insult has been seen in the 
distal ileum and cecum by measuring the passage of Cr-EDTA, together with an increased amount of 
translocating bacteria in mesenteric lymphnodes and liver as compared to control animals without any 
injury [29]. As endotoxin is implicated in the progression of D-galactosamine-induced liver injury [30], 
simultaneous  administration  of  LPS  from  Escherichia  coli  is  often  used  in  order  to  increase  the 
severity of the model. In such settings, intestinal bacteria were seen to invade the mucosa nine hours 
after the insult and a simultaneous collapse of TJ integrity was observed in the mice. The authors 
discussed  the  possibility  that  destroyed  polarity  may  have  facilitated  the  translocation  between 
epithelial cells [31]. 
The  probiotic  mixture  VSL#3  (one  strain  each  of  L.  plantarum,  Lactobacillus  casei, 
Lactobacillus delbrueckii  subsp.  bulgaricus,  Lactobacillus  acidophilus,  Bifidobacterium  breve, 
Bifidobacteriun infantis, Bifidobacterium longum and Streptococcus salivarius subsp. thermophilus) 
was challenged for its effect in an acute liver injury model in the mice induced by D-galactosamine and 
LPS. The diseased control group of mice showed a breakdown of colonic barrier function, as measured 
by  mannitol  movement  in  the  Ussing  chamber,  which  is  a  device  where  intestinal  pieces  can  be 
mounted and the flux of different molecules from the mucosal to the serosal side monitored. The 
increase in permeability of mannitol was concomitant with an increase of pro-inflammatory cytokines Nutrients 2011, 3  
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in  colon  tissue  as  well  as  bacterial  translocation  to  the  liver  and  hepatic  injury.  In  a  peroxisome 
proliferator-activated receptor-gamma (PPAR-γ) dependent manner, the pre-treatment by probiotics 
before insult prevented the permeability increase as well as the elevated translocation and the liver 
injury [32]. Although the probiotic used in that study was a mixture of strains from different species as 
well as genera, pre-treatment by a single strain of lactobacilli has given similar outcomes in this model. 
Decreased translocation of bacteria to mesenteric lymph nodes and liver, as well as to arterial and 
portal blood, increased DNA and RNA content of mucosal tissue, and reduced hepatocyte damage 
(as indicated by a decrease in the release of liver enzymes) was obtained  after pre-treatment with 
L. plantarum 299v [33,34].  
2.3. Dextran Sulfate-Induced Colitis 
Increased  epithelial  permeability  is  intimately  linked  to  the  inflammation  process  in  IBD.  The 
etiology of IBD, mainly ulcerative colitis (UC) and Crohn’s disease (CD), is not known but it has been 
proposed  that  the  excessive  immunological  reactivity  partly  depends  on  the  increased  intestinal 
permeability  [17].  Even  though  it  has  been  shown  that  there  are  alterations  in  the  TJ  complex, 
concomitant to increased permeability during inflammation, the question remains as to whether the 
change in permeability is a prerequisite of inflammation or vice versa [35]. 
Administration of dextran sulfate sodium (DSS) to rodents has been widely used as a model for 
inducing acute and chronic colitis, as both clinical and histopathological outcomes resemble those of 
human ulcerative colitis [36]. The DSS model for mice shows that one of the earliest events is the loss 
of ZO-1. This  is  followed by an  increase  in intestinal  permeability, followed by higher scores  in 
disease activity index (DAI) as well as inflammation [35].  
In a recent study of DSS given to rats, the probiotic mixture of strain mixture VSL3 was shown to 
counteract  apoptosis  and  protect  against  increased  intestinal  permeability  by  up-regulation  of  the 
expression of proteins of the tight junctions, namely of occludin, ZO-1 and claudines 1–5 [37]. Again, 
the treatment comprised a mixture of strains of different species and genera as outlined above, but 
effects of single strains of lactobacilli in this model have also been shown. L. plantarum DSM 9843 
(299v), L. plantarum 15313, and L. fermentum 35D have also been shown to counteract the increase in 
DAI after DSS treatment [38–40]. When colon mucosal infiltration of neutrophils and oxidative stress 
were measured as myeloperoxidase (MPO) and malondialdehyde (MDA), respectively, L. plantarum 
15313 and L. fermentum 35D significantly decreased the MPO, while L. plantarum DSM 9843 and 
L. plantarum 15313 were able to reduce the MDA [39,40].  
The effect of both heat-killed and live L. rhamnosus OLL2838 on DSS-treated BALB/c mice has 
recently been studied in detail. While it suppressed both weight-loss and promoted colon length it also 
restored intestinal barrier function. According to the authors, the protection against increased mucosal 
permeability  observed  ―may  at  least  partially  be  because  of  the  increased  expression  of  zonula 
occludens-1 (4.8 fold) and myosin light-chain kinase (3.1 fold) in intestinal epithelial cells isolated 
from mice of the heat-killed group‖ [41]. Myosin light-chain phosphorylation is regarded as leading to 
contraction of the cytoskeleton and increased paracellular permeability [4]. However, DSS treatment 
and inhibition of myosin light-chain kinase (MLCK) have been shown to induce apoptosis of intestinal Nutrients 2011, 3  
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epithelial  cells.  Accordingly,  normalization  by  L.  rhamnosus  OLL2838  of  the  MLCK  activity,  as 
mentioned above, might have contributed to barrier restoration [41]. 
2.4. Alcohol-Induced Injury 
Alcohol intoxication is associated with an increased translocation of bacteria from the gut as well as 
endotoxemia  [42],  which  could  partly  depend  on  gut  leakiness  mediated  by  increased  oxidative 
stress [43]. The transcription factor NF-κB has been demonstrated to be up-regulated by alcohol [44] 
and thereby increase the inducible nitric oxide synthase and thus the production of reactive nitrogen 
species.  This  oxidative  stress  promotes  carbonylation  and  nitrotyrosination  of  the  actin  and 
microtubule cytoskeletons, leading to loss in tight junction integrity [45].  
In  a  recent  study  of  alcohol  injury  in  the  rat,  L.  rhamnosus  GG  reduced  the  alcohol-induced 
intestinal leakage and decreased oxidative stress in both small intestine and colon, as shown by lower 
carbonyl and nitrotyrosine levels in the probiotic treatment group. Moreover, MPO as a marker of 
neutrophil infiltration and inflammation in colon was significantly reduced by the administration of 
L. rhamnosus GG [43]. 
2.5. Stress-Induced Models 
Stress is known to affect gastrointestinal functions, such as gut motility, and to impair the barrier 
function by increasing the paracellular permeability [20]. Animal models of both acute and chronic 
stress have been developed with manifestations of enhanced bacterial adherence to and internalization 
of the gut wall, increased translocation and altered gut permeability [46,47].  
In a chronic stress model induced by water avoidance, elevated base line short-circuit current and 
increased conductance in the Ussing chamber were noted along with increased bacterial adhesion, 
penetration  and  translocation.  The  baseline  short  circuit  current  and  transepithelial  electrical 
resistance (TER) are parameters that could be monitored in the Ussing chamber and that depend on 
the movement of ions across the paracellular pathway. The probiotic strains L. rhamnosus R0011 (95%) 
and  Lactobacillus  helveticus  R0052  (5%)  had  no  effect  on  intestinal  permeability  as  such  but 
counteracted the elevated base-line short-circuit current and the translocation of bacteria to mesenteric 
lymph nodes [46]. The same Lactobacillus preparation was used in a rat model of maternal stress 
where the pups were separated from the dam for three hours per day from day 4 to day 19. The stressed 
animals without treatment showed increased stimulated short-circuit current and elevated permeability 
to horseradish peroxidase. The adhesion to and penetration of bacteria to epithelial cells was increased 
by the stress whereas the lactobacilli counts were less than in non-stressed pups. Probiotic treatment 
ameliorated these abnormalities. In the meantime, the elevated serum corticosterone levels obtained by 
maternal stress were restored at ―non-stressed‖ levels in the probiotic treatment group. The authors 
conclude that ―probiotics improve gut dysfunction induced by maternal separation, at least in part by 
normalization of HPA axis activity‖ [48].  
Hypersensitivity to distension has been connected to an altered colonic paracellular permeability 
resulting from epithelial cell cytoskeleton contraction through myosin light chain kinase activation [49]. 
Visceral sensitivity and paracellular permeability were  monitored using maternal stress as well as 
partial  restraint  stress  (PRS;  2  h/day  restriction  of  body  movement)  with  the  aim  of  testing  the Nutrients 2011, 3  
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counteractive effect of three different probiotic strains on the adverse manifestations. L. paracasei 
NCC2461  but  not  Bifidobacterium  lactis  NCC362  or  Lactobacillus  johnsonii  NCC533  improved 
stress-induced  visceral  pain  and  restored  normal  gut  permeability  in  the  maternal  stress  model. 
Furthermore,  in  order  for  this  strain  to  prevent  PRS-induced  hypersensitivity,  both  bacteria  and 
bacterial  products  were  required  [50].  A  member  of  the  species  Lactobacillus  farciminis,  strain  
CIP 103136, could prevent the acute stress-induced hypersensitivity to distension and the increase in 
paracellular permeability provoked in a similar PRS model. Treatment by this strain counteracted the 
otherwise increased phosphorylation of the myosin light chain that is characteristic for this model. 
Nitric oxide production of the strain was implicated as playing a role [51].  
2.6. Healthy Animals 
There is no doubt that evidence for the effect of lactobacilli on paracellular permeability in animal 
models  is  increasing,  but  studies  in  healthy  animals  are  few.  However,  it  has  been  shown  in 
Sprague-Dawley rats that administration of L. plantarum 299v counteracts the otherwise increased 
passage of mannitol across the small intestinal wall induced by a non-pathogenic strain of E. coli.  
This was measured in the Ussing chamber and, interestingly, the prevention was only obtained when 
the lactobacilli were administered in the drinking water but not via tube feeding twice a day [52].  
The authors discuss the possibility of the received quantity being responsible for this discrepancy. 
Around four times more lactobacilli were ingested via the water as compared to tube feeding but, in 
light of the stress-evoked manifestations on permeability mentioned above, the fact that the animals 
were tube-fed twice a day could have been of importance for the outcome. In any case, L. plantarum 299v 
administered for one week in the drinking water could protect from E. coli-induced permeability in 
perfectly healthy animals. 
3. Effects in Different Cell Systems 
In order to find effects and to understand underlying mechanisms of lactobacilli on paracellular 
permeability, monolayers of different epithelial cell lines have been used as models. Proinflammatory 
factors such as ROS, specific cytokines and toxins of enteropathogenic bacteria can act by disrupting 
the tight junction and thereby compromising the intestinal barrier function. Tumor necrosis factor 
alpha (TNF-α) induces intestinal barrier impairment both in vitro and in vivo [53,54]. In vitro, TER 
could be used as a means of detecting intestinal barrier dysfunction of cell monolayers. Decrease in 
TER and increased permeability has been associated with down-regulation of ZO-1 and changes in the 
junctional localization [55], partly depending on increased expression and activation of the myosin 
light-chain  (MLC)  kinase  protein  [56].  L.  plantarum  ATCC  8014  was  shown  to  inhibit  the  
TNF-α-induced disturbance of TER as well as the increased IL-8 secretion in Caco-2 cells. Moreover, 
activation of extracellular signal-regulated kinase (ERK) and degradation of transcription factor NF-κB 
inhibitor  IκB-α  was  counteracted  by  this  strain  [57].  Four  different  strains  of  lactobacilli 
(L. delbrueckii  subsp.  bulgaricus  No.  3,  L.  casei  No.  3,  Lactobacillus  gasseri  No.  10,  and 
L. rhamnosus OLL2838) were tested in a similar Caco-2 model and only the L. rhamnosus strain gave 
significant normalization of TER and decrease of IL-8 secretion as compared to TNF-α-induced cells 
without any treatment [41]. These authors also tested the supernatant of L. rhamnosus OL2838 but no Nutrients 2011, 3  
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effect on TER or IL-8 was obtained. On the other hand, when L. rhamnosus GG was challenged in 
Caco-2  cells  treated  by  hydrogen  peroxide  where  this  compound  destroys  TER  and  increases 
permeability, it became clear that secreted proteins of this strain were effective against the insult. They 
prevented the hydrogen peroxide-induced redistribution of occludin, ZO-1, E-cadherin, and β-catenin 
from the intercellular junctions. This effect was brought about by the activation of ERK1/2 and protein 
kinase C isoforms PKCβ1 and PKCε [58]. 
Infection  by  pathogenic  E.  coli  (EPEC)  increases  paracellular  permeability  of  colonic  cells. 
Philpott et al. [59] recorded a decrease in TER and a change in ZO-1 distribution in T84 cells three 
hours after infection, and later it was shown that EPEC-induced MLC-phosphorylation was involved in 
this disturbance [60]. L. casei DN-114001 inhibited, in a dose-dependent manner, such effects on TER 
and ZO-1 both when coincubated and when added three hours after infection [61]. A preventive effect 
on EPEC-induced increase in short-circuit current has also previously been described for L. plantarum 
299v  [62].  For  enteroinvasive  E.  coli  (EIEC),  another  strain  of  the  latter  species  (L.  plantarum 
CGMCC No. 1258) counteracted both the decrease of TER and increase in permeability of the dextran 
probe that was brought about by this infection on Caco-2 cells. The lower expression, as well as the 
redistribution of claudin-1, occludin, JAM-1, and ZO-1, was prevented. In fact, the L. plantarum strain 
itself made the tight junction proteins concentrate at the cellular contact sites where they are known  
to stabilize the integrity of Caco-2 cells. Moreover, L. plantarum CGMCC No. 1258 reversed the 
EIEC-induced alteration of peri-junctional actin filaments [63]. 
4. Effects in Human Studies 
Although  there  is  impressive  evidence  of  lactobacilli  influencing  paracellular  permeability  in 
animal models and cell systems, studies of such effects in humans are rare. However, in a very recent 
publication, a small but elegant randomized, crossover study in humans showed that L. plantarum 
WCFS1 affected relocation of ZO-1 and occludin of duodenal cells [15], in accordance with that of  
L. plantarum CGMCC No. 1258 on Caco-2 colonic cells mentioned above [63]. More precisely, these 
proteins were found, by fluorescent staining of biopsies, to be significantly increased in the vicinity of 
the tight junction structures six hours after administration of the lactobacilli at this site as compared to 
administration of placebo in the same person. In Caco-2 cells, concomitant with activating TLR-2, 
L. plantarum WCFS1 was shown to protect against the drop in TER that was provoked by phorbol 12, 
13 dibutyrate. This chemical is known to dislocate ZO-1 and occludin from the tight junction area. 
Activation of TLR2 by a TLR2 agonist attenuated the effects of the phorbol ester, just as did the  
L. plantarum strain. The authors conclude that their findings ―provide a highly plausible explanation 
for  the  reported  effects  of  L.  plantarum  and  other  probiotic  strains  on  barrier  disruption  by 
inflammatory cytokines, chemicals and infection agents‖ [15].  
This conclusion is very likely to be true for such a rapid effect on permeability as the one described 
above. However, other mechanisms could be at work, especially in a longer time frame. L. plantarum 
299v has been shown to decrease IL-8 production of colonic epithelial cells while adhering to mannose 
at the surface of those [64]. This may counteract infiltration of neutrophils and  thereby increased 
paracellular permeability. The adhesion property of this strain has also been seen to play a pivotal role 
in reducing bacterial translocation in endotoxemic rats [65]. Specific strains, also when adhering to Nutrients 2011, 3  
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epithelial cells, upregulate production of MUC3 mucin that, in turn, prevents pathogenic E. coli from 
attaching and from executing its effects on paracellular permeability [62,66,67]. Moreover, effects by 
lactobacilli on the very composition and/or activity of the entire microbiota might, in this complex 
ecosystem, affect the paracellular permeability. 
Clinical Trials 
Clinical trials challenging the effect of probiotics on intestinal permeability are few and sometimes 
inconclusive. In a prospective randomized trial in critically ill patients, L. plantarum 299v was given 
by enteral feeding as compared to conventional therapy. No differences between the groups were 
found in terms of septic morbidity or mortality and only a trend towards lower intestinal permeability 
was recorded as measured by lactulose/rhamnose ratio for the group receiving L. plantarum. However, 
at  fifteen  days  of  treatment,  the  serum  IL-6  was  significantly  lower  in  the  probiotic  group  [68]. 
Furthermore, in a placebo controlled study of critically ill patients treated by antibiotics, L. plantarum 
299v was shown to reduce the colonization of Clostridium difficile and, in a sub-group of patients in 
this study, the lactulose/rhamnose excretion ratio was monitored and found to be improved in the 
group receiving the probiotic as compared to the placebo group [69]. One reason for the conflicting 
results could be that in the latter study, the daily dose of the probiotic bacteria was approximately  
10-times higher than in the previously described study. 
The paracellular permeability of colonic biopsies from patients with irritable bowel syndrome (IBS) 
turned out to be increased compared to those from healthy persons. This was associated with a lower 
expression of ZO-1 mRNA in biopsies of IBS. When soluble factors from the biopsies were harvested, 
those from IBS patients decreased ZO-1 expression and increased TER in Caco-2 cells as compared to 
those  from  healthy  subjects.  This  effect  on  increased  paracellular  permeability  was  positively 
correlated  with  severity  of  abdominal  pain  of  the  participants  [19].  L.  plantarum  299v  has  been 
administered  in  randomized,  double  blinded,  placebo  controlled trials  to  IBS  patients,  where  they 
experienced relief in their symptoms including significantly less bloating and abdominal pain [70,71]. 
In children, the effect of L. rhamnosus GG has been addressed in two different patient groups, 
namely children with atopic dermatitis and children with short bowel syndrome. In a double-blinded, 
placebo-controlled,  cross-over  study,  intake  of  this  probiotic  meant  that  the  children  with  atopic 
dermatitis  experienced  fewer  gastrointestinal  symptoms.  At  the  end  of  the  study,  the  lactulose  to 
rhamnose ratio was lower in the probiotic group than in the placebo group, and a positive correlation 
was found between this ratio and the severity of eczema [72]. In contrast, no significant effect on the 
lactolose to mannitol ratio was obtained in the trial done on children with short bowel syndrome [73]. 
5. Conclusions 
Maintaining paracellular permeability in the gut at a normal level is a very central function that is 
compromised in many disease situations. Already 15 years ago, certain strains of lactobacilli were 
shown to have the ability to counteract the increased intestinal permeability provoked by methotrexate 
in the rat. Since then, a lot of data along these lines has been gathered, mainly in different animal 
models and in vitro cell systems. Although probiotics could contribute to the overall intestinal barrier 
function  by  increasing  mucin  production,  by  immunomodulation,  by  pathogen  inhibition  and  by Nutrients 2011, 3  
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influencing the entire microbiota, the time has come to really challenge the effect of probiotics on 
paracellular permeability per se in humans.  
References 
1.  Groschwitz,  K.R.;  Hogan,  S.P.  Intestinal  barrier  function:  Molecular  regulation  and  disease 
pathogenesis. J. Allergy Clin. Immunol. 2009, 124, 3–20. 
2.  Keita,  Å.V.;  Sö derholm,  J.  The  intestinal  barrier  and  its  regulation  by  neuroimmune  factors. 
Neurogastroenterol. Motil. 2010, 22, 718–733. 
3.  Gonzá lez-Mariscal,  L.;  Tapia,  R.;  Chamorro,  D.  Crosstalk  of  tight  junction  components  with 
signaling pathways. Biochim. Biophys. Acta 2008, 1778, 729–756. 
4.  Shen, L.; Su, L.; Turner, J.R. Mechanisms and functional implications of intestinal barrier defects. 
Dig. Dis. 2009, 27, 443–449. 
5.  Koch, S.; Nusrat, A. Dynamic regulation of epithelial cell fate and barrier function by intercellular 
junctions. Ann. N. Y. Acad. Sci. 2009, 1165, 220–227. 
6.  Harris,  C.E.;  Griffiths,  R.D.;  Freestone,  N.;  Billington,  D.,  Atherton,  S.T.;  Macmillan,  R.R. 
Intestinal permeability in the critically ill. Intensive Care Med. 1992, 18, 38–41. 
7.  O’Boyle, C.J.; MacFie, J.; Mitchell, C.J.; Johnstone, D.; Sagar, P.M.; Sedman, P.C. Microbiology 
of bacterial translocation in humans. Gut 1998, 42, 29–35. 
8.  Hernandez, G.; Velasco, D.; Waintre, C.; Castillo, L.; Bugedo, G.; Maiz, A.; Lopez, F.; Guzman, S.; 
Vargas, C. Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J. Crit. 
Care 1999, 14, 73–77. 
9.  Klarin, B. Using probiotics in intensive care with special reference to Lactobacillus plantarum 
299 and 299v. Ph.D. Thesis, Lund University, Lund, Sweden, October 2008. 
10.  Marshall, J.C.; Christou, N.V.; Meakins, J.L. The gastrointestinal tract. The ―undrained abscess‖ 
of multiple organ failure. Ann. Surg. 1993, 218, 111–119. 
11.  Meakins, J.L.; Marshall, J.C. The gastro-intestinal tract: the motor of multiple organ failure. Arch. 
Surg. 1986, 121, 197–201. 
12.  Nieuwenhuijzen,  G.A.P.;  Goris,  R.J.A.  The  gut:  the  motor  of  multiple  organ  dysfunction 
syndrome? Curr. Opin. Clin. Nutr. Metab. Care 1999, 2, 399. 
13.  Gatt,  M.;  Reddy,  B.S.;  MacFie,  J.  Review  article:  bacterial  translocation  in  the  critically  
ill—evidence and methods of prevention. Aliment. Pharmacol. Ther. 2007, 25, 741–757. 
14.  Karczewski,  J.;  Troost,  F.J.;  Konings,  I.;  Dekker,  J.;  Kleerebezem,  M.;  Brummer,  R.-J.M.;  
Wells, J.M. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum 
in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 
2010, 298, G851–G859. 
15.  Sheth, P.; Delos Santos, N.; Seth, A.; LaRusso, N.F.; Rao, R.K. Lipopolysaccharide disrupts tight 
junctions in cholangiocyte monolayers by c-Scc-, TLR4-, and LPB-dependent mechanism. Am. J. 
Physiol. Gastrointest. Liver Physiol. 2007, 293, G308–G318. 
16.  Laukoetter, M.G.; Nava, P.; Nusrat, A. Role of intestinal barrier in inflammatory bowel disease. 
World J. Gastroenterol. 2008, 14, 401–407. Nutrients 2011, 3  
 
 
114 
17.  Fö rster, C. Tight junctions and the modulation of barrier function in disease. Histochem. Cell Biol. 
2008, 130, 55–70. 
18.  Piche, T.; Barabara, G.; Aubert, P.; Bruley dê s Varannes, S.; Dainese, R.; Nano, J.L.; Cremon, C.; 
Strangellini, V.; de Giorgio, R.; Galmiche, J.P.; Neunlist, M. Impaired intestinal barrier integrity 
in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 
2009, 58, 196–201. 
19.  Eutamene, H.; Bueno, L. Role of probiotics in correction abnormalities of colonic flora induced 
by stress. Gut 2007, 56, 1495–1497. 
20.  Ahrné ,  S.;  Nobaek,  S.;  Jeppsson,  B.;  Adlerberth,  I.;  Wold,  A.;  Molin,  G.  The  normal 
Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 1998, 85, 88–94. 
21.  Visser,  J.;  Rozing,  A.;  Sapone,  A.;  Lammers,  K.;  Fasano,  A.  Tight  junctions,  intestinal 
permeability and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann. N. Y. Acad. 
Sci. 2009, 1165, 195–205. 
22.  Maeda,  T.;  Miyasono,  Y.;  Ito,  K.;  Hamada,  K.;  Sekine,  S.;  Horie,  T.  Oxidative  stress  and 
enhanced permeability in the small intestine of methotrexate rats. Cancer Chemother. Pharmacol. 
2010, 65, 1117–1123. 
23.  Sheth, P.; Basuroy, S.; Li, C.; Naren, A.P.; Rao, R.K. Role of phosphaditylinositol 3-kinase in 
oxidative stress-induced disruption of tight junctions. J. Biol. Chem. 2003, 278, 49239–49245. 
24.  Rao, R.K.; Basuroy, S.; Rao, V.U.; Kamaky, K.J., Jr.; Gupta, A. Tyrosine phosphorylation and 
dissociation  of  occluding-ZO-1  and  E-caderin-beta-catenin  coplexes from  the  cytoskeleton  by 
oxidative stress. Biochem. J. 2002, 368, 471–481. 
25.  Mao, Y.; Nobaek, S.; Kasravi, B.; Adawi, D.; Stenram, U.; Molin, G.; Jeppsson, B. The effects of 
Lactobacillus  strains  and  oat  fiber  on  methotrexate-induced  enterocolitis  in  the  rats. 
Gastroenterology 1996, 111, 334–344. 
26.  Southcott, E.; Tooley, K.L.; Howart, G.S.; Davidsson, G.P.; Butler, R.N. Yoghurts containing 
probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats. Dig. Dis. 
Sci. 2008, 53, 1837–1841. 
27.  Blitzer, B.L.; Waggoner, J.G.; Jones, E.A.; Gralnick, H.R.; Towne, D.; Butler, J.; Weise, V.; 
Kopin, I.; Walters, I.; Teychenne, P.F.; Goodman, D.G.; Berk, P.D. A model of fulminant hepatic 
failure in rabbit. Gastroenterology 1978, 74, 664–671. 
28.  Lehmann, V.; Freudenberg, M.A.; Galanos, C. Lethal toxicity of lipopolysaccharide and tumor 
necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 1987, 165, 657–663. 
29.  Kasravi,  B.;  Wang,  L.;  Wang,  X.-D.;  Molin,  G.;  Bengmark,  S.;  Jeppsson,  B.  Bacterial 
translocation in acute liver injury induced by D-galactosamine. Hepatology 1996, 23, 97–103. 
30.  Nolan, J.P. Endotoxin, reticuloendothelial function in liver injury. Hepatology 1981, 1, 458–465. 
31.  Song, H.-L.; Lv, S.; Liu, P. The roles of tumor necrosis factor-alpha in colon tight junction protein 
expression  and  intestinal  mucosa  structure  in  a  mouse  model  of  acute  liver  failure.  BMC 
Gastroenterol. 2009, 9, 70. 
32.  Ewaschuk, J.; Endersby, R.; Thiel, D.; Diaz, H.; Backer, J.; Ma, M.; Churchill, T.; Madsen, K. 
Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model 
of sepsis. Hepatology 2007, 46, 841–850. Nutrients 2011, 3  
 
 
115 
33.  Adawi, D.; Kasravi, B.; Molin, G.; Jeppsson, B. Effect of Lactobacillus supplementation with and 
without arginine on liver damage and bacterial translocation in an acute liver injury model in the 
rat. Hepatology 1997, 25, 642–647. 
34.  Adawi, D.; Molin, G.; Ahrné , S.; Jeppsson, B. Modulation of the colonic bacterial flora affects 
differently bacterial translocation and liver injury in an acute liver injury model. Microb. Ecol. 
Health Dis. 1999, 11, 47–54.  
35.  Poritz, L.S.; Garver, K.I.; Green, C.; Fitzpatrick, L.; Ruggiero, F.; Koltun, W.A. Loss of the tight 
junction protein ZO-1 in dextran sulfate sodium induced colitis. J. Surg. Res. 2007, 140, 12–19. 
36.  Dieleman,  L.A.;  Palmern,  M.J.;  Akol,  H.;  Bloemena,  E.;  Pena,  A.S.;  Meuwissen,  S.G.;  
van  Rees,  E.P.  Cronic  experimental  colitis  induced  by  dextran  sulphate  sodium.  Clin.  Exp. 
Immunol. 1998, 114, 385–391. 
37.  Menningen,  R.;  Nolte,  K.;  Rijken,  E.;  Utech,  M.;  Loeffler,  B.;  Senninger,  N.;  Bruewer,  M. 
Probiotic  mixture  VSL#3  protects  the  epithelial  barrier  by  maintaining  tight  junction  protein 
expression and preventing apoptosis in a murine model of colitis. Am. J. Physiol. Gastrointest. 
Liver Physiol. 2009, 296, G1140–G1149. 
38.  Osman, N.; Adawi, D.; Ahrné , S.; Jeppsson, B.; Molin, G. Modulation of the effect of dextran 
sulfate  sodium-induced  acute  colitis  by  the  administration  of  different  probiotic  strains  of 
Lactobacillus and Bifidobacterium. Dig. Dis. Sci. 2004, 49, 320–327. 
39.  Osman, N.; Adawi, D.; Ahrné , S.; Jeppsson, B.; Molin, G. Probiotics and blueberry attenuate the 
severity of dextran sulfate sodium (DSS) induced colitis. Dig. Dis. Sci. 2008, 53, 2464–2473. 
40.  Osman, N. Effects of probiotics and plant components on murine experimental colitis and acute 
liver failure. Ph.D. Thesis, Lund University, Lund, Sweden, September 2006. 
41.  Miyauchi,  E.;  Morita,  H.;  Tanabe,  S.  Lactobacillus  rhamnosus  alleviates  intestinal  barrier 
dysfunction in part by increasing expression of zonula occludens-1 and myosin light chain kinase 
in vivo. J. Dairy Sci. 2009, 92, 2400–2408. 
42.  Choudry,  M.A.;  Rana,  S.N.;  Kavanaugh,  M.J.;  Kovacs,  E.J.;  Gamelli,  R.L.;  Sayed,  M.M. 
Impaired intestinal immunity and barrier function: a cause for enhanced bacterial translocation in 
alcohol intoxication and burn injury. Alcohol 2004, 33, 199–208. 
43.  Forsyth, C.B.; Farhadi, A.; Jakate, S.M., Tang, Y.; Shaikh, M.; Keshavarzian, A. Lactobacillus 
GG  treatment  ameliorates  alcohol-induced  intestinal  oxidative  stress,  gut  leakiness,  and  liver 
injury in a rat model of alcoholic steatohepatitis. Alcohol 2009, 43, 163–172. 
44.  Banab, A.; Keshavarzian, A.; Zhang, L.; Shaikh, M.; Forsyth, C.B.; Tang, Y.; Fields, J.Z. NF-κB 
activation  as  a  key  mechanism  in  ethanol-induced  disruption  of  the  F-actin  cytoskeleton  and 
monolayer barrier integrity in intestinal epithelium. Alcohol 2007, 41, 447–460. 
45.  Farhadi, A.; Keshavarzian, A.; Ranjbaran, Z.; Fields, J.Z.; Banan, A. The role of protein kinase C 
isoforms in modulating injury and repair of the intestinal barrier. J. Pharmacol. Exp. Ther. 2006, 
316, 1–7. 
46.  Zareie, M.; Johnson-Henry, K.; Jury, J.; Yang, P.-C.; Ngan, B.-Y.; McKay, D.M.; Sö derholm, J.D.; 
Perdue,  M.H.;  Sherman,  P.M.  Probiotics  prevent  translocation  and  improve  intestinal  barrier 
function in rats following chronic physiological stress. Gut 2006, 55, 1553–1560. Nutrients 2011, 3  
 
 
116 
47.  Demaude, J.; Salvador-Cartier, C.; Fioramonti, J.; Ferrier, L.; Bueno, L. Phenotypic changes in 
colonocytes following acute stress or activation of mast cells in mice: implications for delayed 
epithelial barrier barrier dysfunction. Gut 2006, 55, 655–661. 
48.  Gareau, M.G.; Jury, J.; MacQueen, G.; Sherman, P.M.; Perdue, M.H. Probiotic treatment of rat 
pups normalizes corticosterone release and ameliorates colonic dysfunction induced by maternal 
separation. Gut 2007, 56, 1522–1528. 
49.  Ait-Belgnaoui, A.; Bradesi, S.; Fioramonti, S.; Teodorou, V.; Bueno, L. Acute stress-induced 
hypersensitivity to colonic distension depends upon increases in paracellular permeability: role of 
myosin light chain kinase. Pain 2005, 113, 141–147. 
50.  Eutamene,  H.;  Lamine,  F.;  Chabo,  C.;  Theodorou,  V.;  Rochat,  F.;  Bergoncelli,  G.E.;  
Chorthé sy-Theulaz, I.; Fioramonti, J.; Bueno, L. Synergy between Lactobacillus paracasei and its 
bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats.  
J. Nutr. 2007, 137, 1901–1907. 
51.  Ait-Belgnaoui, A.; Han, W.; Lamine, F.; Eutamene, H.; Fioramonti, J.; Bueno, L.; Theodorou, V. 
Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible 
action through interaction with epithelial cell cytoskeleton contraction. Gut 2006, 55, 1090–1094. 
52.  Mangell,  P.;  Nejdfors,  P.;  Wang,  M.;  Ahrné ,  S.;  Weströ m,  B.;  Thorlacius,  H.;  Jeppsson,  B. 
Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig. Dis. 
Sci. 2002, 47, 511–516. 
53.  Li,  Q.;  Zhang,  Q.;  Wang,  M.;  Zhao,  S.;  Ma,  J.;  Juo,  N.;  Li,  N.;  Li,  Y.;  Xu,  G.;  Li,  J.  
Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering 
lipid composition in micro domains of tight junction. Clin. Immunol. 2008, 126, 67–80. 
54.  Mazzon, E.; Cuzzocrea, S. Role of TNF-alpha in ileum tight junction alteration in a mouse model 
of restraint stress. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G1268–G1280. 
55.  Ma,  T.Y.;  Iwamoto,  G.K.;  Hoa,  N.T.;  Akoti,  V.;  Pedram,  A.;  Boivin,  M.A.;  Said,  H.M.  
TNF-alpha  induced  increase  in  intestinal  epithelial  tight  junction  permeability  requires  
NF-kappa-B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286, G367–G376. 
56.  Ma, T.Y.; Boivin, M.A.; Ye, D.; Pedram, A.; Said, H.M. Mechanism of TNF-α modulation of 
Caco-2  intestinal  epithelial  tight  junction  barrier:  role  of  myosin  light-chain  kinase  protein 
expression. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288, G422–G430. 
57.  Ko, J.S.; Yang, H.R.; Chang, J.Y.; Seo, J.K. Lactobacillus plantarum inhibits epithelial barrier 
dysfunction  and  interleukin-8  secretion  induced  by  tumor  necrosis  factor-α.  World  J. 
Gastroenterol. 2007, 13, 1962–1965. 
58.  Rao, R.K.; Polk, D.B.; Seth, A.; Yan, F. Probiotics the good neighbor: Guarding the gut mucosal 
barrier. Am. J. Infect. Dis. 2009, 5, 195–199. 
59.  Philpott,  D.J.;  MaKay,  D.M.;  Sherman,  P.M.;  Perdue,  M.H.  Infection  of  T84  cells  with 
enteropathogenic Escherichia coli alters barrier and transport functions. Am. J. Physiol. 1996, 
270, G634–G645. 
60.  Yuhan, R.; Koutsouris, A.; Savkovic, S.D.; Hecht, G. Enteropathogenic Escherichia coli-induced 
MLC phosphorylation alters intestinal permeability. Gastroenterology 1997, 113, 1873–1882. Nutrients 2011, 3  
 
 
117 
61.  Parassol,  N.;  Freita,  M.;  Thoreaux,  K.;  Dalmasso,  G.;  Bourdet-Sicard,  R.;  Rampal,  P. 
Lactobacillus  casei  DN-114001  inhibits  the  increase  in  paracellular  permeability  of 
enteropathogenic Escherichia coli-infected T84 cells. Res. Microbiol. 2005, 156, 256–262. 
62.  Michail, S.; Abernathy, F. Lactobacillus plantarum reduces the in vitro secretory response of 
intestinal epithelial cells to enteropathogenic Escherichia coli infection. J. Pediatr. Gastroenterol. 
2002, 35, 350–355. 
63.  Qin, H.; Zhang, Z.; Hang, X.; Jiang, Y. L. plantarum prevents enteroinvasive Escherichia coli-
induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 2009, 9, 63. 
64.  McCracken, V.J.; Chun, T.; Baldeó n, M.E.; Ahrné , S.; Molin, G.; Mackie, R.; Gaskins, H.R.  
TNF-α sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Exp. Biol. Med. 2002, 
227, 665–670. 
65.  Mangell, P.; Lennernä s, P.; Wang, M.; Olsson, C.; Ahrné , S.; Molin, G.; Thorlacius, H.; Jeppsson, B. 
Adhesive  capability  of  Lactobacillus  plantarum  299v  is  important  for  preventing  bacterial 
translocation in endotoxaemic rats. APMIS 2006, 114, 611–618. 
66.  Mack,  D.R.;  Michail,  S.;  Wei,  S.;  McDougall,  L.;  Hollingsworth,  M.A.  Probiotics  inhibit 
enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. 
Physiol. 1999, 276, G941–G950. 
67.  Mack,  D.R.;  Ahrné ,  S.;  Hyde,  L.;  Wei,  S.;  Hollingworth,  M.A.  Extracellular  MUC3  mucin 
secretion  follows  adherence  of  Lactobacillus  strains  to  intestinal  epithelial  cells  in  vitro.  Gut 
2003, 52, 827–833. 
68.  McNaught, C.E.; Woodcook, N.P.; Andersson, A.D.G.; MacFie, J. A prospective randomized trial 
of probiotics in critically ill patients. Clin. Nutr. 2005, 24, 211–219. 
69.  Klarin, B.; Wullt, M.; Palmquist, I.; Molin, G.; Larsson, A.; Jeppsson, B. Lactobacillus plantarum 
299v reduces colonization of Clostridium difficile in critically ill patients treated with antibiotics. 
Acta Anaesthesiol. Scand. 2008, 52, 1096–1102. 
70.  Nobaek,  S.;  Johansson,  M.-L.;  Molin,  G.;  Ahrné ,  S.;  Jeppsson,  B.  Alteration  of  intestinal 
microflora  is  associated  with  reduction  in  patients  with  irritable  bowel  syndrome.  Am.  J. 
Gastroenterol. 2000, 95, 1231–1238. 
71.  Niedzielin, K.; Kordecki, H.; Birkenfeld, B. A controlled double-blind randomized study on the 
efficacy  of  Lactobacillus  plantarum  299v  in  patients  with  irritable  bowel  syndrome.  Eur.  J. 
Gastroenterol. Hepatol. 2001, 13, 1143–1149. 
72.  Rosenfeldt,  V.;  Benfeldt,  E.;  Valerus,  N.H.;  Paerregaard,  A.;  Michaelsen,  K.F.  Effect  of 
probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic 
dermatitis. J. Pediatr. 2004, 145, 612–616. 
73.  Sentongo, T.A.; Cohran, V.; Korff, S.; Sullivan, C.; Iyer, K.; Zheng, X. Intestinal permeability 
and  effects  of  Lactobacillus  rhamnosus  in  children  with  short  bowel  syndrome.  J.  Pediatr. 
Gastroenterol. Nutr. 2008, 46, 41–47. 
©  2011  by  the authors;  licensee  MDPI,  Basel,  Switzerland.  This  article  is  an  open  access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 